Xencor Inc
XNCR
NASDAQ
Biotechnology
$23.34
USD
+0.35 (+1.52%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $1.70B
Volume 443.1K
Price Target
$44.00 – $44.00
USD
The 1 analysts offering 1-year price forecasts have a max estimate of $44.00 and a min estimate of $44.00.
Past 2Y
1Y Forecast
Price Targets
Average Target
$44.00
+$23.5 vs prior
Implied Upside
+88.5%
+100.7% vs prior
Analyst Covering
1
-1 vs prior period
Consensus
Buy
Improved vs prior
Signal Quality
Consensus Freshness
33%
Many ratings are older - consensus may be less current
Analyst Agreement
High
Targets are closely clustered - analysts agree more than usual
Mean vs Median
$0 Gap
Median and average are closely aligned - few outliers skewing the consensus
Analyst Consensus
Strong Sell
Hold
Strong Buy
Buy
1 Buy
0 Hold
0 Sell
Rating Breakdown
Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0
1 analysts · last 3 months
Covering Analysts
Unlock each analyst's profile, success rate + price targets
Free shows the consensus and each analyst's current rating.
| Analyst | Firm | Rating | Action | Date | Success Rate | Price Target | Implied Upside |
|---|---|---|---|---|---|---|---|
Steve Seedhouse | Cantor Fitzgerald | Buy | Maintained | 1 week ago | Plus | Plus | Plus |
Frequently Asked Questions
Similar Stocks
AVBP
ArriVent BioPharma Inc
$29.51
▼ -1.6%
BCAX
Bicara Therapeutics Inc
$24.28
▲ +2.8%
TYRA
Tyra Biosciences Inc
$25.29
▲ +1.1%
FBRX
Forte Biosciences Inc
$76.83
▼ -0.0%
ABSI
Absci Corp
$9.18
▼ -3.0%
NTLA
Intellia Therapeutics Inc
$11.91
▲ +0.7%
JBIO
Jade Biosciences Inc
$24.71
▲ +3.8%
ZYME
Zymeworks Inc
$25.12
▼ -2.5%
VIR
Vir Biotechnology Inc
$9.24
▲ +2.7%
TRAX
First Tracks Biotherapeutics Inc
$44.04
▲ +0.0%